APA (7th ed.) Citation

JT, M., A, Y., K, H., LC, F., AT, V., D, M., . . . A, B. (2026). Oral delivery of an ustekinumab biosimilar with bioavailability comparable to subcutaneous administration in healthy human participants. European journal of clinical pharmacology, 82(2), 40. https://doi.org/10.1007/s00228-025-03969-6

Chicago Style (17th ed.) Citation

JT, Myers, et al. "Oral Delivery of an Ustekinumab Biosimilar with Bioavailability Comparable to Subcutaneous Administration in Healthy Human Participants." European Journal of Clinical Pharmacology 82, no. 2 (2026): 40. https://doi.org/10.1007/s00228-025-03969-6.

MLA (9th ed.) Citation

JT, Myers, et al. "Oral Delivery of an Ustekinumab Biosimilar with Bioavailability Comparable to Subcutaneous Administration in Healthy Human Participants." European Journal of Clinical Pharmacology, vol. 82, no. 2, 2026, p. 40, https://doi.org/10.1007/s00228-025-03969-6.